Factor concentrates are increasingly used in place of traditional blood products for managing bleeding in critically ill patients. This webcast will explore the current landscape of factor concentrate use—including prothrombin complex concentrate (PCC), fibrinogen concentrate, and recombinant activated factor VII (rFVIIa)—and how they compare to plasma and cryoprecipitate transfusions.
Expert panelists will discuss recent clinical trial data, evolving dosing strategies, and the risks and benefits of these therapies across three high-risk patient populations: trauma, cardiac surgery, and liver transplantation. Participants will gain a deep understanding of how these products are being integrated into modern hemostatic protocols and their potential to improve outcomes in critical care settings.
Participants can earn 1 accredited continuing education (ACE) credit and maintenance of certification (MOC) point. This webcast is held in partnership with SCCM's Anesthesiology Section.
Tuesday, November 4, 2025
1:00 p.m. – 2:00 p.m. Central Time
Please log in or create an account before clicking Register Now.
To log in or create an account, click here or navigate to the menu bar at the top of the page and select Log In then Sign In/Sign Up.
SCCM members receive FREE registration. Not a member? Join today!
Can't make the live event? Register anyway and receive a link to the recording.
Learning Objectives
Staff Anesthesiologist
Red Bank Anesthesia
Red Bank, New Jersey, USA
Professor of Anesthesiology
University of Vermont Medical Center
Burlington, Vermont, USA
Assistant Professor of Anesthesiology and Critical Care Medicine
George Washington University Hospital
Washington, DC, USA
Cardiothoracic Anesthesiologist
University of Virginia
Charlottesville, Virginia, USA
